Charles River Laboratories Announces Third-Quarter 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Needham Starts NeoVolta (NEOV) at Buy
Charles River Labs (CRL) PT Lowered to $464 at Jefferies
November 4, 2021 7:57 AM EDTJefferies analyst David Windley lowered the price target on Charles River Labs (NYSE: CRL) to $464.00 (from $480.00) while maintaining a Buy rating.
The analyst commented, "We are maintaining our Buy rating on 2 key factors: 1) we think demand is strong enough to support DD... More
Charles River Laboratories (CRL) Tops Q3 EPS by 12c, Updates Guidance
November 3, 2021 7:09 AM EDTCharles River Laboratories (NYSE: CRL) reported Q3 EPS of $2.70, $0.12 better than the analyst estimate of $2.58. Revenue for the quarter came in at $895.9 million versus the consensus estimate of $908.19 million.
GUIDANCE:
Charles River Laboratories sees FY2021 EPS of $10.20-$10.30, versus the consensus of... More
